Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

WASEEMULLAH KHAN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1073557864
CMS profile
48213
Location
LAKE CITY, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$4,558.44

158 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,212.04 156
Travel and Lodging $1,334.34 1
Education $12.06 1

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
US Oncology Corporate, Inc. $1,854.61 2
Novartis Pharmaceuticals Corporation $217.11 13
AstraZeneca Pharmaceuticals LP $174.57 10
Merck Sharp & Dohme LLC $154.60 8
Celgene Corporation $138.35 12
E.R. Squibb & Sons, L.L.C. $129.68 7
Amgen Inc. $124.30 7
GENZYME CORPORATION $122.14 6
Bayer HealthCare Pharmaceuticals Inc. $98.98 5
Genentech USA, Inc. $95.88 5
Seagen Inc. $92.34 5
Incyte Corporation $90.94 6
PFIZER INC. $89.54 6
Gilead Sciences, Inc. $78.58 5
EISAI INC. $69.04 4
Lilly USA, LLC $63.52 3
Janssen Biotech, Inc. $63.47 3
Takeda Pharmaceuticals U.S.A., Inc. $63.43 3
Pharmacyclics LLC, an AbbVie Company $59.99 4
Regeneron Healthcare Solutions, Inc. $45.61 2
Elekta, Inc. $43.68 1
Global Blood Therapeutics, Inc. $42.71 3
Alexion Pharmaceuticals, Inc. $41.92 2
Boehringer Ingelheim Pharmaceuticals, Inc. $38.68 2
Astellas Pharma US Inc $38.36 3
Daiichi Sankyo Inc. $34.77 2
Ipsen Biopharmaceuticals, Inc $34.58 2
PUMA BIOTECHNOLOGY, INC. $32.81 2
G1 Therapeutics, Inc. $31.32 2
Blueprint Medicines Corporation $28.03 1
Sun Pharmaceutical Industries Inc. $24.88 2
GlaxoSmithKline, LLC. $22.94 1
Siemens Medical Solutions USA, Inc. $22.22 1
EMD Serono, Inc. $21.01 1
Myriad Genetic Laboratories, Inc. $20.83 1
Octapharma USA, Inc. $19.10 1
BeiGene USA, Inc. $18.57 1
ARRAY BIOPHARMA INC $18.19 1
TOLMAR Pharmaceuticals, Inc. $18.04 1
SERVIER PHARMACEUTICALS LLC $17.76 1
Rigel Pharmaceuticals, Inc. $17.49 1
Sobi, Inc $17.32 1
GE HealthCare $16.27 1
TG Therapeutics, Inc. $15.75 1
ABBVIE INC. $15.55 1
Myovant Sciences Inc. $14.79 1
Adaptive Biotechnologies Corporation $14.76 1
Deciphera Pharmaceuticals Inc. $14.76 1
Kite Pharma, Inc. $13.05 1
Exelixis Inc. $12.79 1
SECURA BIO, INC. $8.83 1

Page 2 of 4; records 51–100 of 158 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

WASEEMULLAH KHAN

NPI 1073557864 · CMS profile ID 48213

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

LAKE CITY, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 158 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1073557864?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
WASEEMULLAH KHAN, NPI 1073557864, CMS profile ID 48213. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 158 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1073557864?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). WASEEMULLAH KHAN, NPI 1073557864, CMS profile ID 48213. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 158 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1073557864?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
WASEEMULLAH KHAN, NPI 1073557864, CMS profile ID 48213, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 158 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1073557864?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

158 matching records · $4,558.44 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 158 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 158.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $19.9908/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932657377 CMS
E.R. Squibb & Sons, L.L.C. $5.6208/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932657379 CMS
Gilead Sciences, Inc. $13.4708/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929632295 CMS
Myovant Sciences Inc. $14.7908/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941216359 CMS
Pharmacyclics LLC, an AbbVie Company $13.0008/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890342383 CMS
PFIZER INC. $14.4208/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949331635 CMS
Lilly USA, LLC $22.3008/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918328315 CMS
Genentech USA, Inc. $23.0508/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950697293 CMS
G1 Therapeutics, Inc. $17.9008/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954033389 CMS
SERVIER PHARMACEUTICALS LLC $17.7608/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964207729 CMS
PFIZER INC. $15.6708/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949352371 CMS
Novartis Pharmaceuticals Corporation $18.5408/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893831241 CMS
E.R. Squibb & Sons, L.L.C. $21.6108/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932657367 CMS
PUMA BIOTECHNOLOGY, INC. $14.6907/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942291123 CMS
E.R. Squibb & Sons, L.L.C. $14.1107/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932657369 CMS
Merck Sharp & Dohme LLC $18.5807/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944205169 CMS
Novartis Pharmaceuticals Corporation $16.4607/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893831237 CMS
Global Blood Therapeutics, Inc. $12.7107/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942709321 CMS
Ipsen Biopharmaceuticals, Inc $13.4707/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893397673 CMS
Seagen Inc. $25.5307/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904085121 CMS
Celgene Corporation $21.0207/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932657365 CMS
Lilly USA, LLC $20.2507/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918291809 CMS
AstraZeneca Pharmaceuticals LP $24.7507/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914787917 CMS
Rigel Pharmaceuticals, Inc. $17.4907/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962275757 CMS
Astellas Pharma US Inc $12.8107/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940220829 CMS
PFIZER INC. $11.8607/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949316725 CMS
Celgene Corporation $12.3207/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932657363 CMS
AstraZeneca Pharmaceuticals LP $12.1607/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915502055 CMS
Gilead Sciences, Inc. $14.8606/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929632297 CMS
Incyte Corporation $16.7506/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943020039 CMS
GlaxoSmithKline, LLC. $22.9406/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944578259 CMS
Siemens Medical Solutions USA, Inc. $22.2206/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892297429 CMS
TOLMAR Pharmaceuticals, Inc. $18.0406/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954473299 CMS
Elekta, Inc. $43.6806/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964010795 CMS
Seagen Inc. $16.9506/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904085111 CMS
Sun Pharmaceutical Industries Inc. $12.7606/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947950487 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.8206/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887714649 CMS
GE HealthCare $16.2706/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953426953 CMS
GENZYME CORPORATION $21.0506/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938846843 CMS
Janssen Biotech, Inc. $28.5406/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885683707 CMS
Takeda Pharmaceuticals U.S.A., Inc. $30.4006/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955683011 CMS
Incyte Corporation $15.9506/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943020031 CMS
AstraZeneca Pharmaceuticals LP $14.8805/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914989687 CMS
Amgen Inc. $17.3605/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939826207 CMS
Alexion Pharmaceuticals, Inc. $24.0205/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915857719 CMS
Daiichi Sankyo Inc. $16.5405/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930807505 CMS
Bayer HealthCare Pharmaceuticals Inc. $14.2505/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929807917 CMS
Merck Sharp & Dohme LLC $16.5705/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944168477 CMS
Celgene Corporation $0.3405/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932657343 CMS
Celgene Corporation $13.3205/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932657345 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,883.25 152
PY2020 $1,895.57 113
PY2021 $2,584.15 143
PY2022 $4,558.44 158
PY2023 $3,338.16 162
PY2024 $4,152.90 157
PY2025 $2,690.05 133

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $2,344.76 4
PY2023 Principal investigator $9,423.25 2
PY2022 Principal investigator $350.00 1
PY2021 Principal investigator $831.25 2
PY2020 Principal investigator $14,993.25 3
PY2019 Principal investigator $23,071.51 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Sumitomo Pharma America, Inc. $637.88 04/17/2024 Non-covered Recipient Entity
LAKE CITY CANCER CARE LLC DBA CANCER CARE AND URO
RELUGOLIX VERSUS LEUPROLIDE IN PATIENTS WITH PROSTATE CANCER: A RANDOMIZED, OPEN-LABEL STUDY TO ASSESS MAJOR ADVERSE CARDIOVASCULAR EVENTS (REPLACE-CV) No dispute reported 06/30/2026 1148431052
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $137.50 03/07/2024 Non-covered Recipient Entity
Lake City Cancer Care Llc
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice No dispute reported 06/30/2026 1155196573
Principal investigator 1 Sumitomo Pharma America, Inc. $784.69 01/24/2024 Non-covered Recipient Entity
LAKE CITY CANCER CARE LLC DBA CANCER CARE AND URO
RELUGOLIX VERSUS LEUPROLIDE IN PATIENTS WITH PROSTATE CANCER: A RANDOMIZED, OPEN-LABEL STUDY TO ASSESS MAJOR ADVERSE CARDIOVASCULAR EVENTS (REPLACE-CV) No dispute reported 06/30/2026 1148431048
Principal investigator 1 Sumitomo Pharma America, Inc. $784.69 01/24/2024 Non-covered Recipient Entity
LAKE CITY CANCER CARE LLC DBA CANCER CARE AND URO
RELUGOLIX VERSUS LEUPROLIDE IN PATIENTS WITH PROSTATE CANCER: A RANDOMIZED, OPEN-LABEL STUDY TO ASSESS MAJOR ADVERSE CARDIOVASCULAR EVENTS (REPLACE-CV) No dispute reported 06/30/2026 1148431050